Samsung Biologics

Share on: 
Description: 

Provided cell-line development to commercial manufacturing of drug substance and product, to biosafety testing services, all from a single location.

COVID-19: Signed a $362M contract with Vir Biotechnology to manufacture VIR-7831 and VIR-7832.

Location(s): 
Incheon
South Korea